Institut Bergonié

GROUPE JEAN-MICHEL COINDRE, BINH NGUYEN BUI

Objectifs

CONTICANET aims at setting up a network of excellence as a vehicle to create the critical mass of researchers, clinicians and industrialists able to: - Improve the understanding of carcinogenesis and tumour progression of connective tissue cancers in adults and children and specifically of sarcomas, GIST, aggressive fibromatosis and hamartomas. - Develop new diagnostic tools, prevention strategies and treatments for these connective tissue cancers in adults and children. The main goals of CONTICANET are to: - Create the critical mass of key stakeholders from translational, pharmacological and clinical research to make a real breakthrough in connective tissue cancers diagnosis and management both for adults and children. - Capitalise on pre-existing collaborations to set up, implement and update a joint research programme and then an European wide organisation covering pre-clinical and clinical research on connective tissue cancers with a patient to patient approach. - Make available to all participants a strong network of facilities accelerating research output.

From this integration, CONTICANET will provide the ground for the development of new treatments and, from an industrial point of view, to: - Establish synergisms between data and models acquired by academics and drug development from the pharmaceutical industry to improve therapeutic options for both adults and children. - Validate some of those options with competent authorities as a model for orphan disease.

Étape en cours : Mise en place de la version 2 des bases de données Européennes, rédaction des articles concernant les projets d’épidémiologie sur 3 régions Européennes, plusieurs projets de recherche biologique coopératifs

Ouverture réglementaire : Février 2006

Fin des inclusions : Juillet 2011

Vue complète de l'étude en cours (PDF) : cliquer ici